NIH Deputy Director: NIH Interesting Times, Challenging Times

Tuesday, September 24, 2013 - 9:00am to 10:00am

Keith Yamamoto, Ph.D., Vice Chancellor of Research & University Relations
Invite you to attend a lecture by

Sally J. Rockey, Ph.D.

Deputy Director for Extramural Research National Institutes of Health

“NIH: Interesting Times, Challenging Times”

Tuesday, September 24, 2013 9:00-10 a.m.
Byers Auditorium Genentech Hall, Mission Bay 

Please join us in welcoming Dr. Sally Rockey, Deputy Director for Extramural Research, National Institutes of Health, to UC San Francisco. In her address, “NIH: Interesting Times, Challenging Times,” Dr. Rockey will discuss the painful paradox that is confronting biomedical research in the United States – scientific progress is moving faster than ever. However, due to arbitrary across-the-board spending cuts, scientific innovation in America faces its greatest threat ever.

Dr. Sally J. Rockey is the Deputy Director for Extramural Research, leading extramural research activities at NIH. The Office of Extramural Research (OER), which she also serves as Director, is the focal point for policies and guidelines for extramural research administration within NIH and in partnership with the biomedical research community.

Extramural grants represent more than 80% of the $31.2 billion NIH budget.
These are awarded to investigators throughout the U.S. and abroad. Through its approximately 1,200 individuals and $112 million budget, the Office of Extramural Research (OER) provides the infrastructure that makes these grants happen. OER provides the corporate framework for NIH research administration, ensuring scientific integrity, public accountability, and effective stewardship of the NIH research grant portfolio with the ultimate goal of preserving public trust in research. OER serves as a vital interface between the NIH and the biomedical research community by guiding investigators through the process of attaining grants funding and helping them understand and navigate through federal policies and procedures.

Ensuring the future of U.S competitiveness and innovation in biomedical research is of the upmost importance to NIH. One avenue for achieving this goal is to support a sustainable and diverse workforce. To this end, in 2011-12, Dr. Rockey co-chaired the NIH Advisory Committee to the Director on the Biomedical Research Workforce, which developed a workforce model to inform decisions about training the right number of people for the relevant positions that will advance science and promote health.

To attend Dr. Rockey’s lecture, please RSVP to by Friday, September 20. Space is limited. 

Event flyer